Malaria still has a devastating impact on public health and welfare in Cameroon. Despite the
increasing number of studies conducted on disease prevalence, transmission patterns or …

Malaria is a vector-and blood-borne infection that is responsible for a large number of
deaths around the world. Most of the currently used antimalarial therapeutics suffer from …

Background Efficient allocation of resources to intervene against malaria requires a detailed
understanding of the contemporary spatial distribution of malaria risk. It is exactly 40 y since …

Background The worldwide epidemics of diseases as dengue and Zika have triggered an
intense effort to repurpose drugs and search for novel antivirals to treat patients as no …

Malaria, as one of the most common human infectious diseases, remains the greatest global
health concern, since approximately 3.5 billion people around the world, especially those in …

Cerebral malaria occurs due to Plasmodium falciparum infection, which causes 228 million
infections and 450,000 deaths worldwide every year. African people are mostly affected with …

The use of medicinal plants in the treatment of malaria is gaining global attention due to their
efficacy and cost effectiveness. This study evaluated the bioactivity-guided antiplasmodial …

Introduction Artemisinin-based combination therapies (ACTs) are the first-line antimalarial
drugs used to treat uncomplicated Plasmodium falciparum alaria in many endemic countries …

The effects of artesunate, a water-soluble artemisinin derivative, against Babesia species,
including Babesia bovis, Babesia gibsoni and Babesia microti were studied. Cultures of B …

Adherence to artemisinin‐based combination therapy (ACT) is not clearly defined. This meta‐
analysis determines the prevalence and predictors of adherence to ACT. Twenty‐five …